Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-075129
Filing Date
2018-03-08
Accepted
2018-03-08 16:07:31
Documents
84
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d507480d10k.htm 10-K 1223072
2 EX-10.30 d507480dex1030.htm EX-10.30 328566
3 EX-23.1 d507480dex231.htm EX-23.1 1759
4 EX-31.1 d507480dex311.htm EX-31.1 6207
5 EX-31.2 d507480dex312.htm EX-31.2 6139
6 EX-32.1 d507480dex321.htm EX-32.1 4406
13 GRAPHIC g507480g47g25.jpg GRAPHIC 88604
14 GRAPHIC g507480g87d56.jpg GRAPHIC 137342
15 GRAPHIC g507480g90h01.jpg GRAPHIC 137280
  Complete submission text file 0001193125-18-075129.txt   6155161

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT drna-20171231.xml EX-101.INS 895253
8 XBRL TAXONOMY EXTENSION SCHEMA drna-20171231.xsd EX-101.SCH 59363
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20171231_cal.xml EX-101.CAL 74584
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20171231_def.xml EX-101.DEF 188176
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20171231_lab.xml EX-101.LAB 476031
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20171231_pre.xml EX-101.PRE 343942
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36281 | Film No.: 18676542
SIC: 2834 Pharmaceutical Preparations